We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

154 hedge funds and large institutions have $856M invested in Enanta Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 55 increasing their positions, 59 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,057% more call options, than puts

Call options by funds: $7.16M | Put options by funds: $619K

1.87% more ownership

Funds ownership: 95.82% → 97.69% (+1.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

7% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 59

9% less funds holding

Funds holding: 169 → 154 (-15)

39% less capital invested

Capital invested by funds: $1.4B → $856M (-$544M)

52% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 21

Holders
154
Holders Change
-15
Holders Change %
-8.88%
% of All Funds
2.59%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
55
Reduced
59
Closed
21
Calls
$7.16M
Puts
$619K
Net Calls
+$6.54M
Net Calls Change
+$3.81M

Top Buyers

1
AC
Armistice Capital
New York
+$51.3M
2
State Street
State Street
Massachusetts
+$21.2M
3
Invesco
Invesco
Georgia
+$8.55M
4
PBA
Paradigm Biocapital Advisors
New York
+$8.04M
5
JP Morgan Chase
JP Morgan Chase
New York
+$7.49M

Top Sellers

1
First Manhattan
First Manhattan
New York
-$30.5M
2
DTC
Deep Track Capital
Connecticut
-$14.1M
3
SCM
Stonepine Capital Management
Oregon
-$8.54M
4
SCM
Soleus Capital Management
Connecticut
-$5.56M
5
Walleye Capital
Walleye Capital
New York
-$4.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$6.15M +$393K +7,243 +6%
AllianceBernstein
27
AllianceBernstein
Tennessee
$5.97M +$840K +15,475 +14%
CS
28
Candriam SCA
Luxembourg
$5.41M – – –
SCM
29
Soleus Capital Management
Connecticut
$4.73M -$5.56M -102,485 -51%
Ameriprise
30
Ameriprise
Minnesota
$4.58M -$279K -5,141 -5%
HWAM
31
Hennion & Walsh Asset Management
New Jersey
$3.66M -$1.47M -27,074 -26%
EAM
32
Erste Asset Management
Austria
$3.51M – – –
N
33
Nuveen
North Carolina
$3.4M -$3.99M -73,462 -50%
Citigroup
34
Citigroup
New York
$3.11M +$2.02M +37,249 +131%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$2.72M -$130K -2,400 -4%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$2.64M +$112K +2,055 +4%
Legal & General Group
37
Legal & General Group
United Kingdom
$2.61M +$3.75K +69 +0.1%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$2.61M -$131K -2,408 -4%
HIM
39
Hillsdale Investment Management
Ontario, Canada
$2.52M – – –
Marshall Wace
40
Marshall Wace
United Kingdom
$2.37M +$2.72M +50,160 New
PGA
41
Portland Global Advisors
Maine
$2.27M -$285K -5,250 -10%
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.17M +$147K +2,700 +6%
PI
43
Putnam Investments
Massachusetts
$2.03M +$884K +16,293 +61%
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
$2.02M -$1.58M -29,133 -41%
FCMV
45
Foresite Capital Management V
California
$2M – – –
New York State Teachers Retirement System (NYSTRS)
46
New York State Teachers Retirement System (NYSTRS)
New York
$1.91M +$5.43K +100 +0.2%
CSS
47
Cubist Systematic Strategies
Connecticut
$1.77M +$1.8M +33,227 +792%
Ensign Peak Advisors
48
Ensign Peak Advisors
Utah
$1.61M -$218K -4,011 -11%
Public Sector Pension Investment Board (PSP Investments)
49
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.61M – – –
PAMS
50
Pictet Asset Management (Switzerland)
Switzerland
$1.4M +$1.61M +29,629 New
1
2
3 4 5

ENTA Hedge Fund Activity: Q2 2022 in Review

154 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2022, worth a combined $856M — down 39% from $1.4B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ENTA and 10 opened new positions — a net loss of 11 holders — while 59 trimmed existing stakes and 55 added.

The largest buyer was Armistice Capital, adding an estimated $51.3M. The largest seller was First Manhattan, cutting an estimated $30.5M.

  • 154 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2022, down from 169 in Q1 2022.
  • Funds reported $856M of Enanta Pharmaceuticals stock for Q2 2022, down 39% quarter-over-quarter.
  • 10 funds opened new Enanta Pharmaceuticals positions in Q2 2022 and 21 closed out, a net change of -11 holders.
  • The largest Enanta Pharmaceuticals buyer in Q2 2022 was Armistice Capital, an estimated $51.3M added.
  • The largest Enanta Pharmaceuticals seller in Q2 2022 was First Manhattan, an estimated $30.5M sold.

Based on aggregated 13F filings for Q2 2022.